Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression.
Dozynkiewicz MA, Jamieson NB, Macpherson I, Grindlay J, van den Berghe PV, von Thun A, Morton JP, Gourley C, Timpson P, Nixon C, McKay CJ, Carter R, Strachan D, Anderson K, Sansom OJ, Caswell PT, Norman JC. · 2012
Read Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression. by Dozynkiewicz MA, Jamieson NB, Macpherson I, Grindlay J, van den Berghe PV, von Thun A, Morton JP, Gourley C, Timpson P, Nixon C, McKay CJ, Carter R, Strachan D, Anderson K, Sansom OJ, Caswell PT, Norman JC. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3507630.txt.
Introduction
Cell-surface anchors called integrins are normally destroyed after use, and Marta A. Dozynkiewicz leads a large team showing how cancer cells recycle them instead in 2012. The protein Rab25 routes active alpha5beta1 integrin toward lysosomes, the cell's disposal compartments.
Rather than being degraded, those integrins travel back and reappear at the rear of invading cells. A second protein, CLIC3, makes the return trip possible and helps the cell rear let go during movement through tissue-like gels. Without it, invasion and growth signaling falter. In pancreatic cancer patients, CLIC3 levels predict lymph node spread and poor survival, marking this recycling route as a driver of progression worth targeting.
Catalog record
| CREATOR | Dozynkiewicz MA, Jamieson NB, Macpherson I, Grindlay J, van den Berghe PV, von Thun A, Morton JP, Gourley C, Timpson P, Nixon C, McKay CJ, Carter R, Strachan D, Anderson K, Sansom OJ, Caswell PT, Norman JC. |
|---|---|
| YEAR | 2012 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Rab25 and CLIC3 Collaborate to Promote Integrin Recycling from Late Endosomes/Lysosomes and Drive Cancer Progression By Marta A. Dozynkiewicz, Nigel B. Jamieson, Iain MacPherson, Joan Grindlay, Peter V.E. van den Berghe, Anne von Thun, Jennifer P. Morton, Charlie Gourley, Paul Timpson, Colin Nixon, Colin J. McKay, Ross Carter Published in: Developmental Cell DOI: 10.1016/j.devcel.2011.11.008 ABSTRACT Summary Here we show that Rab25 permits the sorting of ligand-occupied, active-conformation α5β1 integrin to late endosomes/lysosomes. Photoactivation and biochemical approaches show that lysosomally targeted integrins are not degraded but are retrogradely transported and recycled to the plasma membrane at the back of invading cells. This requires CLIC3, a protein upregulated in Rab25-expressing cells and tumors, which colocalizes with active α5β1 in late endosomes/lysosomes. CLIC3 is necessary for release of the cell rear during migration on 3D matrices and is required for invasion and maintenance of active Src signaling in organotypic microenvironments. CLIC3 expression predicts lymph node metastasis and poor prognosis in operable cases of pancreatic ductal adenocarcinoma (PDAC). The identification of CLIC3 as a regulator of a recycling pathway and as an independent prognostic indicator in PDAC highlights the importance of active integrin trafficking as a potential drive to cancer progression in vivo. INTRODUCTION Metastasizing cells need to invade the extracellular matrix (ECM) that surrounds tissues and tumors, and must survive and grow within these microenvironments (Sahai, 2005). As they invade, tumor cells form dynamic interactions with the ECM that not only provide traction force for forward motion and ECM remodeling but also promote cell growth and survival (Kumar and Weaver, 2009). Both the motility and the growth and survival of tumor cells are controlled by integrins: transmembrane proteins that interact extracellularly with ECM proteins, such as fibronectin and collagen, and intracellularly with the cytoskeleton and the cell's signaling and vesicular transport machinery (Caswell et al., 2009; Hynes, 2002). Although the ECM protein, fibronectin, is not normally found in adult tissue, it is a very abundant component of the tumor-associated ECM (Zetter, 1993), and the cell's major fibronectin-binding integrin (α5β1) is key to the survival (Lee and Juliano, 2000; O'Brien et al., 1996; Zhang et al., 1995) and migration (Caswell et al., 2007, 2008; Muller et al., 2009) of tumor cells. α5β1 is continuously endocytosed and then returned, or recycled, to the plasma membrane via Rab11- and Arf6- dependent pathways (Powelka et al., 2004; Roberts et al., 2001; Tayeb et al., 2005). Membrane trafficking pathways mediating α5β1 recycling influence its capacity to promote cancer invasion. Expression of p53 mutants or inhibition of αvβ3 integrin can drive recruitment of the Rab11 effector, Rab-coupling protein (RCP), to the cytotail of β1 integrin, which then enables RCP to associate with the EGF receptor 1 (EGFR1). α5β1 and EGFR1 are then coordinately recycled to the plasma membrane in a way that potentiates EGFR1 signaling to Akt, a kinase that promotes invasion (Caswell et al., 2008; Muller et al., 2009), cell growth, and survival. Another Rab11 family member, Rab25, is associated with aggressive cancers (Caswell et al., 2007; Cheng et al., 2004), and drives invasion by binding to α5β1 to control its recruitment to the tips of invasive projections (Caswell et al., 2007). There is also evidence that Rab25 can suppress tumor progression. Nam et al. (2010) have shown that loss of Rab25 promotes intestinal neoplasia, and low levels of Rab25 are associated with human colorectal cancer. Rao and coworkers (Cheng et al., 2006, 2010) have found that Rab25 expression is reduced in many breast tumors, and its loss in estrogen-receptor-negative breast cancer cell lines promotes aggression. These discrepancies led us to further investigate the mechanisms by which Rab25 influences invasive behavior in vitro and the progression of cancer in vivo. We show that Rab25 directs conformationally active α5β1 integrin to the lysosome. Lysosomally routed α5β1 is not degraded but is rapidly recycled to the plasma membrane via a pathway requiring the Chloride Intracellular Channel Protein 3 (CLIC3). CLIC3 is required for cell migration and is associated with activated integrin signaling both in ex vivo 3D microenvironments and in human tumors. Moreover, CLIC3 levels dictate metastasis and poor patient survival, thus highlighting the importance of integrin trafficking to cancer progression in vivo. RESULTS CLIC3 Is Upregulated in a Rab25 and 3D Matrix-Dependent Fashion We plated A2780 cells stably expressing either Rab25 (A2780-Rab25) or a control vector (A2780-DNA3) onto plastic or cell-derived matrix (CDM)—a thick, pliable matrix composed mainly of fibrillar collagen and fibronectin that recapitulates aspects of the matrix found in connective tissues—and compared their mRNA profiles using Affymetrix arrays. We ranked gene expression changes primarily according to the less conservative step-up p value (one that controls for false discovery rate) and secondarily according to fold changes (see Table S1 available online), and this revealed CLIC3 to be the most significant Rab25-upregulated gene when cells were plated onto CDM, but not following adherence to plastic surfaces (Figure 1A). To confirm CLIC3 induction, mRNA from A2780-DNA3 and A2780-Rab25 cells was analyzed by real-time quantitative PCR (qPCR). CLIC3 mRNA was induced 6-fold by Rab25 on plastic dishes, and this increased to >20-fold when cells were adherent to CDM (Figure 1B). Moreover, CLIC3 mRNA expression in A2780-Rab25 cells was reduced by siRNA of Rab25 (but not Rab11) (Figures 1B and 1C), indicating that altered regulation of CLIC3 levels was not due to clonal variation between the two A2780 lines but was Rab25 specific. We generated a highly specific polyclonal antibody that recognized CLIC3, but not CLIC1 and CLIC4: the two CLIC family members most closely related to CLIC3 (Figure 1D). Our anti-CLIC3 recognized a protein of the expected molecular weight (27 kDa) that was abundant in lysates from A2780-Rab25 cells but barely detectable in control cells (Figure 1E). Moreover, CLIC3 protein levels were somewhat increased by plating A2780-Rab25 cells on CDM (Figure 1F), and this was opposed by knockdown of Rab25 (Figure 1C). Conversely, siRNA of CLIC3 did not alter Rab25 levels (Figure 1G). To evaluate the relationship between Rab25 and CLIC3 expression in tumor cells, we compared their mRNA and protein levels in a large cohort of pancreatic and ovarian tumors (see Figure S1 for validation of Rab25 and CLIC3 antibodies). Rab25 and CLIC3 levels correlated with one another in both pancreatic and ovarian carcinoma (Figure 1H). These data indicate that elevated Rab25 is associated with enhanced CLIC3 expression both in a cell culture model and human tumors. Rab25-Dependent Sorting of Ligand-Engaged α5β1 to CLIC3-Positive Late Endosomes/Lysosomes In glass-attached A2780-Rab25 cells, Cherry-CLIC3 was not present at early (EEA1) or recycling (Rab11) endosomes (Figures S2A and S2B) but colocalized with the late endosomal marker Rab7 (Figure S2C), and was particularly coincident with LAMP1, Sialin (Figures 2A and 2B), and lysotracker (Figure S2D), which are well-established markers of late endosomes/lysosomes. Many Rab25-positive structures colocalized with Rab11a and internalized transferrin, particularly in the perinuclear region, consistent with previous observations that this GTPase is located at recycling endosomes (Figure 2C) (Casanova et al., 1999). Nevertheless, many Rab25-positive structures did not colocalize with Rab11a or internalized transferrin but displayed marked coincidence with LAMP1 (Figure 2C) and Rab7 (data not shown), indicating that Rab25 was also present at late endosomes. Moreover, Rab11a did not colocalize with LAMP1, indicating that late and recycling endosomes are morphologically distinct in